Chronic toxicity of methamphetamine: Oxidative remodeling of pulmonary arteries

Li-Ye Liang1, Meng-Meng Wang2, Ming Liu3

  • 1Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, PR China.

Insights

Methamphetamine (MA) abuse causes lung artery remodeling by disrupting the redox balance in pulmonary arterial smooth muscle cells (PASMCs). Targeting Nrf2 may treat MA-induced lung toxicity.

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Cell Biology

Background:

  • Methamphetamine (MA) is known to affect the lungs, but the exact mechanisms of lung toxicity are not fully understood.
  • Pulmonary arterial remodeling is a significant concern in MA abuse.

Purpose of the Study:

  • To investigate the role of MA abuse in pulmonary artery remodeling.
  • To explore the correlation between MA-induced remodeling and redox imbalance in pulmonary arterial smooth muscle cells (PASMCs).

Main Methods:

  • Wistar rats were exposed to MA.
  • Histological examination (H&E staining), western blot, immunofluorescence, and siRNA knockdown were utilized.
  • PASMC cultures were used to study cellular mechanisms.

Main Results:

  • Chronic MA exposure led to pulmonary arterial remodeling, increased pulmonary arterial pressure, and right ventricular hypertrophy in rats.
  • MA induced an imbalance between proliferation and apoptosis in PASMCs by altering key protein expressions (PCNA, Bcl-2, BAX, Caspase 3).
  • MA inhibited Nrf2 nuclear translocation, leading to increased oxidative stress (ROS) and PASMC proliferation, with Nrf2 knockdown exacerbating these effects.

Conclusions:

  • Chronic MA exposure induces pulmonary arterial remodeling via Nrf2-mediated redox imbalance and oxidative stress.
  • Nrf2 plays a critical role in MA-induced lung toxicity, suggesting it as a potential therapeutic target.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
667
Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems01:15

Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
355
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
645
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
646